Immunome’s (IMNM) efficient execution in 2024 laid the foundation for a productive 2025,” said Clay B. Siegall, Ph.D., President and Chief ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

A teenage cricket star who survived three rounds of chemotherapy and still carries a tumour which affects his batting has ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Jennifer Fisher joins Rossana Scotto to discuss jewelry and diagnoses with a Desmoid Tumor. Plus, Keri Glassman talks about all-natural form of Ozempic ...

Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

BOTHELL, WA, USA I March 10, 2025 I Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted ...

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

A Grinnell couple’s dream to help other families after they lost their son to a rare disease took a big step forward at Iowa ...

(NASDAQ:SWTX) is dedicated to developing targeted therapies for rare diseases and cancer. The company focuses on high unmet medical needs and its key products include OGSIVEO (nirogacestat) for ...

Detailed price information for Springworks Therapeutics Inc (SWTX-Q) from The Globe and Mail including charting and trades.